Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-067690·LUO DAWEI
Schedule 13G ownership disclosure
VIVOS THERAPEUTICS INC
Common stock, par value $0.0001 per share · CUSIP: 92859E207
Event date: 2025-07-08
- Filing-level shares
- 572,016.00
- Percent of class
- 8.52%
- Dawei Luo
Shares: 572,016.00 · Class: 8.52%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-067690
- Form type
- SCHEDULE 13G
- Filer
- LUO DAWEI
- CIK
- CIK 2077013
- Filed
- Jul 14, 2025
- Reporting period
- Jul 08, 2025
- Description
- Schedule 13G beneficial ownership